Log in
Enquire now
‌

US Patent 11459305 Processes for the preparation of uracil derivatives

Patent 11459305 was granted and assigned to Neurocrine Biosciences on October, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Neurocrine Biosciences
Neurocrine Biosciences
Current Assignee
Neurocrine Biosciences
Neurocrine Biosciences
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11459305
Date of Patent
October 4, 2022
Patent Application Number
16739263
Date Filed
January 10, 2020
Patent Citations
‌
US Patent 10494347 Processes for the preparation of uracil derivatives
Patent Citations Received
‌
US Patent 12102637 Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
0
Patent Primary Examiner
‌
Deepak R Rao
CPC Code
‌
C07D 239/54
‌
A61K 31/513

The present invention relates to processes and intermediates for preparing Gonadotropin-Releasing Hormone (GnRH) receptor antagonists of structure (VI); and stereoisomers and pharmaceutically acceptable salts thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11459305 Processes for the preparation of uracil derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.